1. Home
  2. AIZ vs LEGN Comparison

AIZ vs LEGN Comparison

Compare AIZ & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assurant Inc.

AIZ

Assurant Inc.

HOLD

Current Price

$282.78

Market Cap

13.9B

Sector

Finance

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$18.69

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIZ
LEGN
Founded
1892
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.9B
5.9B
IPO Year
2003
2020

Fundamental Metrics

Financial Performance
Metric
AIZ
LEGN
Price
$282.78
$18.69
Analyst Decision
Buy
Strong Buy
Analyst Count
6
12
Target Price
$256.83
$61.33
AVG Volume (30 Days)
257.6K
1.6M
Earning Date
05-05-2026
05-12-2026
Dividend Yield
1.51%
N/A
EPS Growth
17.08
N/A
EPS
11.34
N/A
Revenue
$12,814,300,000.00
N/A
Revenue This Year
$7.39
$42.68
Revenue Next Year
$5.52
$30.52
P/E Ratio
$24.73
N/A
Revenue Growth
7.89
N/A
52 Week Low
$205.01
$16.24
52 Week High
$303.94
$37.50

Technical Indicators

Market Signals
Indicator
AIZ
LEGN
Relative Strength Index (RSI) 46.69 38.34
Support Level $271.96 $17.81
Resistance Level $284.12 $19.36
Average True Range (ATR) 4.18 0.89
MACD -0.81 -0.01
Stochastic Oscillator 18.19 4.04

Price Performance

Historical Comparison
AIZ
LEGN

About AIZ Assurant Inc.

Assurant Inc is a protection company that partners with the brands to safeguard and service connected devices, homes and automobiles. It operate in North America, Latin America, Europe and Asia Pacific through two operating segments: Global Lifestyle and Global Housing. Global Lifestyle: includes mobile device solutions, consumer electronics and appliances services, and financial services and other insurance products. Global Housing: includes lender-placed homeowners, manufactured housing and flood insurance, as well as voluntary manufactured housing, condominium and homeowners insurance. In addition, the Company reports the Corporate and Other segment, which includes corporate employee-related expenses, activities of the holding company and investments in the home warranty business.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: